Amy Wakeham | ResMed Inc. |
Michael J. Farrell | ResMed, Inc. |
Brett A. Sandercock | ResMed, Inc. |
James Hollingshead | ResMed, Inc. |
David Pendarvis | ResMed, Inc. |
Robert Andrew Douglas | ResMed, Inc. |
Saul Hadassin | UBS Securities Australia Ltd. |
Margaret M. Kaczor | William Blair & Co. LLC |
Anthony Petrone | Jefferies LLC |
David Bailey | Macquarie Securities (Australia) Ltd. |
David A. Low | JPMorgan Securities Australia Ltd. |
Thomas Yeo | Goldman Sachs Australia Pty Ltd. |
Sean Laaman | Morgan Stanley Australia Ltd. |
John Deakin-Bell | Citigroup Global Markets Australia Pty Ltd. |
Andrew Goodsall | MST Financial Services Pty Ltd. |
Welcome to the Q4 Fiscal Year 2018 ResMed Incorporated Earnings Conference Call. My name is Tim and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session. Please note that this conference is being recorded.